Home › Grants › PAR-25-104

Open

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Federal funding opportunity PAR-25-104 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes October 25, 2027

Posted
November 5, 2024
Closes
October 25, 2027
Cost sharing
No
Instrument
Grant
Assistance listing
93.399
Category
Education, Health
Archives
November 30, 2027

Program funding history

Awards made under Assistance Listing 93.399 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$167M
FY2025 obligated
$172.1M
FY2026 (to date) obligated
$8.8M
Awards in window
151

Top recipients: Ecog-acrin Medical Research Foundation, Inc., Nrg Oncology Foundation Inc, Alliance Nctn Foundation, Fred Hutchinson Cancer Center, Oregon Health & Science University

Source: USAspending.gov · refreshed July 2026

Synopsis

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source.

View on Grants.gov   Full announcement

Agency contact: National Institutes of Health · grantsinfo@nih.gov · 301-402-2541

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.

The free edition carries one clearly labeled sponsor slot. No spam, ever. Privacy

Similar grants

Never miss a funding deadline again

Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.

Get funding alerts